ZYLM (Central Asia Lumeichun Biotechnology) Revenue: $1.36 Mil (TTM As of Jun. 2026)

Central Asia Lumeichun Biotechnology  (OTCPK:ZYLM) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.

Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.

Central Asia Lumeichun Biotechnology Revenue Related Terms

The historical data trend for Central Asia Lumeichun Biotechnology's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Central Asia Lumeichun Biotechnology Revenue Chart

Central Asia Lumeichun Biotechnology Annual Data
	Trend	Mar07	Mar08	Mar09	Mar10	Mar11	Mar14	Mar15	Aug23	Dec24	Dec25
Revenue		Get a 7-Day Free Trial					0.37	0.00	0.37	0.93	1.21

Central Asia Lumeichun Biotechnology Quarterly Data
	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun13	Jun15	Sep15	Dec15	Nov22	Feb23	May23	Aug23	Mar25	Jun25	Sep25	Dec25	Mar26	Jun26
Revenue	Get a 7-Day Free Trial															0.22	0.19	0.48	0.36	0.33

ZYLM vs RHE, DVCR, FVE: Revenue Comparison

For the Farm Products subindustry, Central Asia Lumeichun Biotechnology's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Central Asia Lumeichun Biotechnology Revenue vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Central Asia Lumeichun Biotechnology's Revenue distribution charts can be found below:

* The bar in red indicates where Central Asia Lumeichun Biotechnology's Revenue falls into.

Central Asia Lumeichun Biotechnology Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.36 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Central Asia Lumeichun Biotechnology Business Description